Evidence-based mostly pointers issued in 2014 by the American Academy of Neurology concluded that nabiximols might be successful for enhancing subjective spasticity symptoms, in all probability ineffective for minimizing objective spasticity actions or bladder incontinence, And maybe ineffective for reducing various sclerosis–connected tremor.NSA